In the TME, senescent tumor cells may increase antitumor immune responses by secreting IL-6, IL-8, and insulin-like growth factor binding protein 7 (IGFBP7) with the ability of recruiting immune cells such as T lymphocytes to the tumor site [21]. Here, IGFBP7 is linked to neoplasm.